膀胱癌의 한의학적 진료지침 개발을 위한 기초 연구

키워드

참고문헌 (77)

1. Ploeg M, "The present and future burden of urinary bladder cancer in the world", World J Urol, 27(3), pp.289~293 (2009)
2. Kiemeney LA, "The risk of cancer in the Netherlands", Nederlands tijdschrift voor geneeskunde, 152(41), pp.2233~2241 (2008)
3. 국가암등록사업 연례보고서(2012년 암등록통계), "중앙암등록본부", 보건복지부 중앙암등록본부, ~ (2014)
4. Zeng C, "Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010", JAMA oncology, 1(1), pp.88~96 (2015)
5. 국가암등록사업 연례 보고서(2006년 암발생, 1993-2006년 암생존 현황), "중앙암등록본부", 보건복지부 중앙암등록본부, ~ (2009)
6. 허준, "원본 동의보감" (2014), 남산당
7. 홍원식, "황제내경소문" (1992), 전통문화연구회
8. 赵红星, "中药运用对膀胱癌介入化疗术后不良反应的影响", 中华中医药学刊, 10 (2013)
9. 邹鹏, "非肌层浸润性膀胱癌的中西医治疗研究进展", 亚太传统医药, 01 (2015)
10. 马成杰, "膀胱癌的中西医结合诊治", 中国临床医生, 05 (2007)
11. 朱剑勇, "中医药辅助治疗对膀胱癌术后患者生存质量的影响", 辽宁中医杂志, 09 (2013)
12. 曾晔, "中西医结合治疗浅表性膀胱癌30例", 中医研究, 05 (2009)
13. Park T, "Clinical Experiences of Korean Medicine Treatment against Urinary Bladder Cancer in General Practice", Evidence-based complementary and alternative medicine : eCAM, 2016, pp.3759069~ (2016)
14. Network NCC, "Bladder Cancer (NCCN Guidelines)", ~ (2015)
15. Cancer NCCf, "Bladder cancer: diagnosis and management", ~ (2015)
16. 대한비뇨기종양학회, "방광암 진료지침" (2005), 대한비뇨기종양학회
17. 林洪生, "惡性腫瘤中醫診療指南", pp.521~539 (2014), 人民衛生出版社
18. Recommendations for Development of Clinical Practice Guideline in Korean Medicine (PRIDE-CPG-KM), "Lee MS", Korea Institute of Oriental Medicine, ~ (2013)
19. Kogevinas M, "Occupation and bladder cancer among men in Western Europe", Cancer Cause Control, 14(10), pp.907~914 (2003)
20. Freedman ND, "Association Between Smoking and Risk of Bladder Cancer Among Men and Women", Jama-J Am Med Assoc, 306(7), pp.737~745 (2011)
21. 郭文鹏, "膀胱癌湿热瘀毒蕴积病因病机与其有氧糖酵解代谢异常相关", 环球中医药, 01, pp.59~62 (2015), 假说的提出
22. Khadra MH, "A prospective analysis of 1,930patients with hematuria to evaluate current diagnostic practice", J Urol, 163(2), pp.524~527 (2000)
23. Satoh E, "Prediction of muscle invasion of bladder cancer by cystoscopy", Eur Urol, 41(2), pp.178~181 (2002)
24. Lotan Y, "Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses", Urology, 61(1), pp.109~118 (2003)
25. Kamat AM, "Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity", BJU Int, 108(7), pp.1119~1123 (2011)
26. Datta SN, "Urinary tract ultrasonography in the evaluation of haematuria-a report of over 1,000 cases", Annals of the Royal College of Surgeons of England, 84(3), pp.203~205 (2002)
27. Herr HW, "Routine CT scan in cystectomy patients: does it change management?", Urology, 47(3), pp.324~325 (1996)
28. Tekes A, "Dynamic MRI of bladder cancer: evaluation of staging accuracy", AJR American journal of roentgenology, 184(1), pp.121~127 (2005)
29. Apolo AB, "Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography", computed tomography in bladder cancer, 2010, pp.28(25), 3973~3978
30. Epstein JI EJ, "World Health Organization Classification of Tumors" (2004), IARC Press
31. Lagwinski N, "Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases", The American journal of surgical pathology, 31(12), pp.1777~1787 (2007)
32. Grignon DJ, "Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases", Cancer, 67(8), pp.2165~2172 (1991)
33. Edge S, "AJCC Cancer Staging Manual" (2010), Springer
34. Culp SH, "Refining patient selection for neoadjuvant chemotherapy before radical cystectomy", J Urol, 191(1), pp.40~47 (2014)
35. Babjuk M, "EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013", Eur Urol, 64(4), pp.639~653 (2013)
36. Miladi M, "The value of a second transurethral resection in evaluating patients with bladder tumours", Eur Urol, 43(3), pp.241~245 (2003)
37. Dalbagni G, "Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer", Eur Urol, 56(6), pp.903~910 (2009)
38. Fuge O, "Immunotherapy for bladder cancer", Research and reports in urology, 7, pp.65~79 (2015)
39. Sylvester RJ, "The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials", Eur Urol, 53(4), pp.709~719 (2008)
40. Raj GV, "Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer", J Urol, 177(4), pp.1283~1286 (2007)
41. Grossman HB, "Bladder cancer: chemoprevention, complementary approaches and budgetary considerations", Scandinavian journal of urology and nephrology. Supplementum, 2008(218), pp.213~233 (2008)
42. Lee RK, "Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes", BJU Int, 113(1), pp.11~23 (2014)
43. Griffiths G, "International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA0630894 trial", Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29(16), pp.2171~2177 (2011)
44. Leow JJ, "Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials", Eur Urol, 66(1), pp.42~54 (2014)
45. James ND, "Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer", The New England journal of medicine, 366(16), pp.1477~1488 (2012)
46. Pal SK, "Optimizing systemic therapy for bladder cancer", Journal of the National Comprehensive Cancer Network :JNCCN, 11(7), pp.793~804 (2013)
47. Asgari MA, "Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: A comparative study", Urology annals, 5(3), pp.190~196 (2013)
48. Perez-Jacoiste Asin MA, "Bacillus Calmette-Guerin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature", Medicine, 93(17), pp.236~254 (2014)
49. 彭蕴茹, "金匮肾气丸防治小鼠肾阳虚的实验研究", 中成药, 05, pp.395~397 (2004)
50. 韩磊, "知柏地黄丸的药理作用和临床应用研究进展", 中国药房, 15, pp.1430~1432 (2012)
51. 张颖, "八珍汤抗肿瘤及补气血的药理临床研究进展", 现代中西医结合杂志, 12, pp.1876~1877 (1998)
52. 沈先东, "八珍汤治疗肿瘤相关性贫血疗效观察", 中医药临床杂志, 05, pp.401~403 (2010)
53. 刘雅, "当归补血汤对气虚血瘀大鼠免疫功能及相关基因的调控", 中药药理与临床, 05, pp.10~13 (2009)
54. 郭刚, "十全大补汤抑制肿瘤侵袭, 转移的研究概述", 环球中医药, 01, pp.74~76 (2011)
55. 刘群英, "补中益气汤治疗脾虚证作用机制研究", 现代中西医结合杂志, 07, pp.799~804 (2011)
56. 李滨, "补中益气汤抗肿瘤作用的实验研究", 中医药学报, 01, pp.22~23 (2006)
57. 王蕾, "针刺加补中益气汤治疗妇科术后膀胱麻痹30例体会", 中国乡村医药, 12, pp.49~50 (2006)
58. 贾瑞明, "旋覆代赭汤及其加减方预防肿瘤化疗后恶心呕吐临床随机对照试验的Meta分析", 吉林中医药, 03, pp.218~219 (2010)
59. 史国军, "旋覆代赭汤加味防治肿瘤化疗后恶心呕吐随机对照试验的Meta分析", 中华肿瘤防治杂志, 23, pp.1881~1884 (2011)
60. 贾淑丽, "橘皮竹茹汤治疗肿瘤化疗的消化反应58例疗效观察", 中医临床研究, 13, pp.46~48 (2011)
61. 王羽, "中西医结合预防化疗引起消化道反应86例临床观察", 四川中医, 08, pp.73~74 (2007)
62. 游向前, "中西医结合预防肿瘤化疗所致呕吐98例", 中国中西医结合杂志, 10, pp.785~787 (2003)
63. 张弦, "八珍汤治疗恶性肿瘤放, 化疗后骨髓抑制30例临床观察", 湖南中医杂志, 04, pp.51~53 (2013)
64. 李宝鸿, "加味当归补血汤对肿瘤患者放化疗增效减毒作用的临床观察附:392例病例报告", 成都中医药大学学报, 02, pp.7~9 (2005)
65. 张梅荣, "加味当归补血汤预防化疗所致白细胞减少的临床观察", 中国中药杂志, 20, pp.174~177 (2006)
66. 王一安, "十全大补汤加减防治化疗毒副反应70例临床观察", 浙江中医杂志, 08, pp.576~ (2011)
67. 郑建军, "十全大补汤对肿瘤患者放化疗减毒作用的观察", 山东中医杂志, 07, pp.395~396 (2000)
68. 齐聪, "十全大补汤对减轻化疗副作用的临床与实验观察", 浙江中医学院学报, 04, pp.16~18 (2000)
69. 赵益, "六味地黄丸对肿瘤细胞抑制作用的研究", 中药新药与临床药理, 06, pp.598~602 (2011)
70. 夏清山, "六味地黄丸在化疗中增效减毒作用的临床观察", 湖北中医杂志, 11, pp.14~15 (2005)
71. Guo Z, "Herbal medicines for advanced colorectal cancer", Cochrane Database Syst Rev, 5, pp.CD004653~ (2012)
72. Su CX, "Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials", Complementary therapies in medicine, 22(3), pp.567~579 (2014)
73. Li SG, "The Efficacy of Chinese Herbal Medicine as an Adjunctive Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis", Plos One, 8(2), pp.e57604~ (2013)
74. 李东芳, "芍药汤加减治疗急性放射性直肠炎36例", 四川中医, 04, pp.47~ (2002)
75. 李爱苓, "子宫颈癌放射治疗致放射性膀胱炎378例临床分析", 中华妇产科杂志, 12, pp.741~743 (1995)
76. 吳玉生, "常見腫瘤病中西醫診療與調養", pp.186~187 (2002), 廣東旅游出版社
77. van Osch FH, "Significant role for lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis", J Urol (2015)

관련 논문AI추천